What is the Market's View on CEL-SCI Corporation (CVM) Stock's Price and Volume Trends Tuesday?

CEL-SCI Corporation (CVM) stock has gained 14.17% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

CEL-SCI Corporation has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on CVM!

See Full CVM Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With CVM Stock Today?

CEL-SCI Corporation (CVM) stock is down -9.27% while the S&P 500 has gained 0.75% as of 10:11 AM on Tuesday, Oct 24. CVM has fallen -$0.14 from the previous closing price of $1.51 on volume of 1,610,239 shares. Over the past year the S&P 500 has gained 11.89% while CVM has fallen -55.66%. CVM lost -$0.78 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for CEL-SCI Corporation click here.

More About CEL-SCI Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia. Click Here to get the full Stock Report for CEL-SCI Corporation stock.